2DR Versus 3DR in a Prospective Randomized Controlled Switch Trial

Abroad (travel likely)RecruitingPHASE4

Conditions

HIV-1-infection

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Ghent University Hospital, Ghent, Belgium
Contact: Study coordinator (Marie-Angelique De Scheerder) · marieangelique.descheerder@ugent.com

Study leads

Linos Vandekerckhove
Principal Investigator
University Hospital, Ghent

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE

HIV -1 Infection · HIV (Human Immunodeficiency Virus) · HIV

Abroad (travel likely)RecruitingPHASE4

Clearwater, United States · Ft. Pierce, United States

A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments

HIV-1-infection

Abroad (travel likely)RecruitingPHASE4

Buenos Aires, Argentina · Panama City, Panama

Change in Body Weight and BMI in PWH with DOR/3TC/TDF Compared with INSTI

HIV · HIV Associate Weight Loss · HIV-1 Infection

Abroad (travel likely)RecruitingPHASE4

Mexico City, Mexico · Mexico City, Mexico

Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants

HIV

Abroad (travel likely)Recruiting

Bethesda, United States